We have previously developed highly sensitive and specific assays to quantify (1) disseminated tumor cells (DTCs) in bone marrow aspirates, (2) GD2 and CD56 (NCAM) cellular levels and (3) ADRN- and MES-type tumor cells based on expression of specific mRNAs [24]. This evidence concerns the gene NCAM1 and neoplasm.